Quick Summary
Gemtide 600mcg Injection
Last updated on 05 Aug 2026 | 06:49 AM (IST)
₹3338
MRP: ₹3750
(You Save ₹412)
1 PREFILLED PEN(s) OF 2.4ML
Gemtide 600 mcg Injection is a prescription medicine used to treat anemia associated with chronic kidney disease or chemotherapy. It contains darbepoetin alfa, which stimulates the bone marrow to produce more red blood cells and improve hemoglobin levels. Gemtide is administered under medical supervision as part of a structured anemia management plan.
Gemtide 600mcg Injection
Salt Composition
TERIPARATIDEMarketer
ALKEM LABORATORIES LTD
Prepaid Only. Non-Returnable.
11% OFF
₹3338
MRP: ₹3,750.00
Inclusive of all taxes
11% Off
Salt Composition
TERIPARATIDEMarketer
ALKEM LABORATORIES LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Gemfrac 600mcg Injection
ALKEM LABORATOR...
₹ 3250.00/injection
2% cheaper
TPT 20 Injection
RPG LIFE SCIENC...
₹ 3970.00/injection
19% costlier
Osteri 600mcg Injection
EMCURE PHARMACE...
₹ 4219.00/injection
27% costlier
Zotide ONE 600mcg Injection 2.4ml
CIPLA LTD
₹ 4696.00/injection
41% costlier
Introduction to Gemtide 600mcg Injection
Gemtide 600 mcg Injection contains the active component as Teriparatide. Gemtide 600 mcg Injection, a synthetic version of parathyroid hormone (PTH) produced by the parathyroid glands, is employed for treating osteoporosis. Osteoporosis is a condition marked by weakened bones, heightening the likelihood of fractures. Fractures caused by osteoporosis can severely affect an individual's quality of life, causing pain and restricting mobility. Gemtide 600 mcg Injection functions by promoting the creation of new bone tissue and enhancing bone mineral density. This medication has been shown to accelerate bone healing in individuals with fractures. It promotes the formation of callus, the initial bridge of new bone that forms during the healing process, leading to faster and more efficient recovery.
Individuals who have a known hypersensitivity or allergic reaction to Gemtide 600 mcg Injection or any of its components should not use this medication. It is contraindicated in individuals with a history of skeletal malignancies, such as osteosarcoma, or those with bone metastases. If an individual has received prior radiation therapy involving the skeleton, the use of this medication is not advised due to the potential risk of osteosarcoma development.
Uses of Gemtide 600mcg Injection
- Postmenopausal osteoporosis
- Glucocorticoid-induced osteoporosis
Therapeutic Effects of Gemtide 600mcg Injection
Gemtide 600 mcg Injection, exerts a therapeutic effect by stimulating the formation of new bone tissue and increasing bone mineral density. By activating osteoblasts, the cells responsible for bone formation, it enhances bone strength, reduces fracture risk, and promotes bone healing. It offers significant benefits such as increased bone density, fracture risk reduction, improved quality of life, and serves as an alternative for individuals who have not responded well to other osteoporosis treatments.
Interaction of Gemtide 600mcg Injection with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with the Gemtide 600 mcg Injection, reducing effectiveness by causing undesirable side effects.
More Information about Gemtide 600mcg Injection
- Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep away from children and pets.
How to consume Gemtide 600mcg Injection
Gemtide 600 mcg Injection is typically administered by a healthcare professional. It is usually given as an injection. The healthcare provider will determine the dosage and duration of treatment based on the specific infection and individual factors.
Safety Advice for Gemtide 600mcg Injection
Breast Feeding
Women should consult a doctor while breastfeeding while taking the Gemtide 600 mcg Injection.
Alcohol
It is generally advisable to avoid consuming alcohol while taking Gemtide 600 mcg Injection. Alcohol can impair the body's immune system, making it less effective in fighting infections.
Liver
If you have a liver condition or are concerned about the safety of Gemtide 600 mcg Injection, it is recommended to consult your healthcare provider for personalized advice.
Lungs
Suppose you have a pre-existing lung condition or are concerned about the safety of the Gemtide 600 mcg Injection in your lungs. Consulting with your healthcare provider for personalized advice is recommended in that case.
Driving
People may experience side effects, including dizziness, drowsiness, or fatigue, after using Gemtide 600 mcg Injection. In that case, avoid driving or operating heavy machinery.
Pregnancy
The safety of Gemtide 600 mcg Injection use during pregnancy has not been established. If you are pregnant or planning to become pregnant, discussing the potential risks and benefits with your healthcare professional is essential.
Side Effects of Gemtide 600mcg Injection
Gemtide 600 mcg Injection cause some side effects like all medications, although not everyone will experience them.
Serious
- Hypercalcemia
- Allergic reactions that affect skin and breathing
- Skin reactions at the injection site include rashes, bruising, swelling, and itching
- Osteosarcoma (type of bone cancer)
- Hypercalcemia (increased level of calcium)
- Orthostatic hypotension (hypertension when stand after sitting or lying position)
Common
- Arthralgia
- Nerve Pain
- Nausea
- Sickness
- Headache
- Dizziness
- Increased sweating
- Breathlessness
- Muscle cramps
- Increase in blood cholesterol levels
- Chest pain
- Burning sensation below the breast bone
- Anaemia
Word of Advice
Prior to initiating Gemtide 600 mcg Injection, it is crucial to disclose any preexisting medical conditions, particularly those related to bones or metabolism, as well as provide information about any medications or supplements being taken, to your healthcare professional. Extra care should be taken for individuals with a history of skeletal malignancies or bone metastases, as Gemtide 600 mcg Injection is not recommended in such cases.
Regular monitoring of serum calcium levels is essential to identify and manage hypercalcemia. In patients with orthostatic hypotension or pre-existing hyperparathyroidism, Gemtide 600 mcg Injection should be used cautiously. The duration of treatment with this medication is generally limited, and its use is not advised in pediatric patients. If you are pregnant or breastfeeding, discussing the potential risks and benefits of Gemtide 600 mcg Injection with your healthcare provider before considering its use is crucial.
FAQs about Gemtide 600mcg Injection
Q1.
Can Gemtide 600 mcg Injection be used in individuals with a history of cancer?
Gemtide 600 mcg Injection is generally not recommended for individuals with a history of cancer, especially skeletal malignancies or bone metastases. The medication has been associated with an increased risk of osteosarcoma, and its safety in individuals with a history of cancer has not been well established.
Q2.
Can Gemtide 600 mcg Injection be used in men with osteoporosis?
Yes, Gemtide 600 mcg Injection can be used in men with osteoporosis. While osteoporosis is more commonly associated with women, men can also develop the condition. It can effectively increase bone density and reduce fracture risk in men with osteoporosis.
Q3.
Can Gemtide 600 mcg Injection be used in individuals with a history of kidney disease?
Gemtide 600 mcg Injection does not undergo significant renal excretion so it can be used in individuals with mild to moderate kidney impairment. However, caution is advised in individuals with severe kidney disease, as there is limited data on the safety and effectiveness of this medication in this population.
Q4.
Can Gemtide 600 mcg Injection be used in individuals with a history of fractures?
Gemtide 600 mcg Injection is commonly prescribed for individuals with a history of fragility fractures. Fragility fractures occur due to minimal trauma or impact and are often associated with osteoporosis. It helps to increase bone density and reduce the risk of future fractures in individuals with osteoporosis, including those who have previously experienced fractures.
Q5.
Can Gemtide 600 mcg Injection be used as a first-line treatment for osteoporosis?
Gemtide 600 mcg Injection is typically not used as a first-line treatment for osteoporosis. It is usually considered when other osteoporosis medications are ineffective, or individuals have a high fracture risk. However, whether it is appropriate as a first-line treatment depends on individual factors and should be discussed with your healthcare provider.
Q6.
What are the potential long-term effects of the Gemtide 600 mcg Injection?
The long-term effects of the Gemtide 600 mcg Injection have yet to be well understood, particularly beyond the recommended treatment duration of 2 years. The risk of osteosarcoma, a potential rare side effect, is one of the main concerns associated with long-term use.
Q7.
What are the side effects of the Gemtide 600 mcg Injection?
Gemtide 600 mcg Injection may cause side effects, including common ones such as injection site reactions, nausea, dizziness, and headache. Serious side effects, though rare, can include the development of osteosarcoma, a type of bone cancer, and the potential for hypercalcemia, which can lead to symptoms like excessive thirst and muscle weakness.
Fact Box of Gemtide 600mcg Injection
Molecule name: Teriparatide
| Therapeutic class: Bone formation stimulator |
Pharmacological class: Parathyroid hormone analogs | Indications: 1. Postmenopausal osteoporosis 2. Glucocorticoid-induced osteoporosis |
References
- Teva UK Limited, Electronic medicines compendium (EMC), [Revised on 26th May 2023], [Accessed on 31st May 2023], https://www.medicines.org.uk/emc/product/11657/pil#gref
- Lilly and Company, US Food and Drug Administration, [Revised on April, 6, 2020] [Accessed on 1st June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021318s053lbl.pdf
- KD Tripathi, Essentials of Medical Pharmacology, Drugs affecting calcium balance, 7th edition, 2013, 339.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. B. Deiva
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 05 Aug 2026 | 06:49 AM (IST)
Want to know more?
Read Our Editorial Policy
